The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: “Maintenance” therapy reconsidered
- 31 October 1992
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 47 (1) , 7-13
- https://doi.org/10.1016/0090-8258(92)90067-s
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Interrupted versus Continuous Chemotherapy in Patients with Metastatic Breast CancerNew England Journal of Medicine, 1991
- Leukemia Following Chemotherapy for Ovarian CancerNew England Journal of Medicine, 1990
- Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study.Journal of Clinical Oncology, 1989
- Treatment of advanced epithelial ovarian cancer with cisplatin and cyclophosphamideGynecologic Oncology, 1989
- Improving the Quality of Life during Chemotherapy for Advanced Breast CancerNew England Journal of Medicine, 1987
- A randomized study of cyclophosphamide and cis-platinum with or without doxorubicin in advanced ovarian carcinomaGynecologic Oncology, 1987
- RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1984
- Acute Leukemia after Alkylating-Agent Therapy of Ovarian CancerNew England Journal of Medicine, 1977
- Survival Curve for Cancer Patients Following TreatmentJournal of the American Statistical Association, 1952
- Survival Curve for Cancer Patients Following TreatmentJournal of the American Statistical Association, 1952